CME Group CEO Sells 43% of His Shares as Stock Nears Record Levels
Key Facts
The filing showed two transactions: the sale of 10,000 shares at an average of $308.54 per share, followed by 17,000 shares at an average of $310.18. This establishes the change in shares directly owned by Duffy, without implying a comparable reduction in his total beneficial ownership. The filing gave no reason for the sale. It also indicated that the Rule 10b5-1 trading-plan box was unspecified, which alone does not establish whether the sale was made under such a plan.
The transactions followed a period of strong activity in the derivatives markets operated by CME. The group said average daily trading volume reached a record 30 million contracts in October, up 15% year over year and above the previous record of 26.3 million contracts in October 2025. The month's activity comprised 14.8 million contracts a day in interest-rate products, 8.8 million in equity indexes, 2.7 million in energy and 2.1 million in agricultural products. The figures show that interest-rate products made up the largest component among the categories cited in October data. Third-quarter volumes also set a record, the company said.
Average daily trading volume was 31.8 million contracts in September, up 22% from September a year earlier, while the third-quarter average was 29.4 million contracts, up 16% year over year. CME said September and third-quarter volumes both exceeded previous records set in 2024. Duffy linked the activity to customers' demand to manage risk and take advantage of opportunities, saying they had turned to the group "in record numbers to manage risk and capitalize on opportunities as uncertainty intensified in the third quarter." These levels provide operational context for the transactions but do not explain Duffy's personal decision to sell. The timing of the sale alongside record trading also does not establish a connection between the two events.
The growth in activity was reflected in the group's quarterly results: CME's third-quarter revenue was $1.7 billion, up 13% from the same period, which the company described as its highest third-quarter revenue on record. Adjusted net income was $1.1 billion, while adjusted diluted earnings per share reached $3.02. Market data revenue set a record of $243 million, up 20% year over year. The company attributed growth in this business to an increase in subscribers, the launch of new products and tools, and price increases that took effect in January 2026. The results show that market data was one source of growing revenue alongside trading activity.
CME shares closed at $306.31 on November 19, according to EL7 data. The close came in the session after the two sale transactions, but the figure alone does not establish the stock's direction before or after the sale or prove that it was near a record level. The closing data are separate from the execution prices in the filing, which showed average prices of $308.54 and $310.18 per share on November 18. On leadership, CME said Duffy will become chairman and chief executive officer on March 1, 2027, while Lynn Fitzpatrick, currently president and chief financial officer, will become chief executive officer. The announcement sets out a planned leadership transition at the group in the coming months.
CME is preparing to launch CME Securities Clearing Inc. on December 7, 2026, subject to the necessary regulatory approvals, to clear U.S. Treasury cash transactions and repurchase agreements. The launch is tied to regulatory requirements for central clearing of some of these transactions: the deadline for eligible cash Treasury transactions is December 31, 2026, while the deadline for eligible repurchase agreements is June 30, 2027. The project expands the group's clearing services alongside its futures and options markets, which contribute to its trading volumes. The service start dates and requirements remain subject to regulatory approvals and the scope of eligible transactions as announced by the company.